| The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane |
40 |
| Platelets in wound healing and regenerative medicine |
33 |
| High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity |
28 |
| Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma |
24 |
| Measuring and interpreting platelet-leukocyte aggregates |
16 |
| Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study |
15 |
| The pro-inflammatory role of platelets in cancer |
14 |
| Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis |
12 |
| Does fibrin(ogen) bind to monomeric or dimeric GPVI, or not at all? |
11 |
| A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: an experimental study in vivo |
11 |
| Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma |
11 |
| Autocrine and paracrine regulatory functions of platelet serotonin |
10 |
| CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis |
10 |
| Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis |
10 |
| Impact of platelet reactivity on long-term prognosis in Korean patients receiving percutaneous coronary intervention |
10 |
| Screening for platelet function disorders with Multiplate and platelet function analyzer |
9 |
| Aspirin, platelet inhibition and cancer prevention |
9 |
| Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model |
9 |
| Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis |
9 |
| Effects of age, gender and menstrual cycle on platelet function assessed by impedance aggregometry |
8 |
| Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study |
8 |
| Structure and function of the open canalicular system - the platelet's specialized internal membrane network |
8 |
| Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane |
7 |
| The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis |
7 |
| High-throughput measurement of human platelet aggregation under flow: application in hemostasis and beyond |
7 |
| Effects of different doses of ticagrelor on platelet aggregation and endothelial function in diabetic patients with stable coronary artery disease |
7 |
| NBEAL2 mutations and bleeding in patients with gray platelet syndrome |
7 |
| The genetics of platelet count and volume in humans |
7 |
| Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling |
7 |
| Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome |
7 |
| Flow cytometry for pediatric platelets |
6 |
| The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: A systematic review |
6 |
| Formin proteins in megakaryocytes and platelets: regulation of actin and microtubule dynamics |
6 |
| Efficacy of platelet concentrates in bone healing: A systematic review on animal studies - Part B: Large-size animal models |
6 |
| Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists |
6 |
| Adenosine A(2A) receptor agonists with potent antiplatelet activity |
6 |
| TBXA2R gene variants associated with bleeding |
6 |
| Megakaryocyte apoptosis in immune thrombocytopenia |
6 |
| Association of thrombocytopenia with in-hospital outcome in patients with acute ST-segment elevated myocardial infarction |
5 |
| Influence of concentration and preparation of platelet rich fibrin on human bone marrow mononuclear cells (in vitro) |
5 |
| Blood collection, platelet isolation and measurement of platelet count and size in mice-a practical guide |
5 |
| Clinical value of the quantitation of average daily platelet increase during the recovery period in childhood acute lymphoblastic leukaemia |
5 |
| The effects of aging, diabetes mellitus, and antiplatelet drugs on growth factors and anti-aging proteins in platelet-rich plasma |
5 |
| RAP GTPases and platelet integrin signaling |
5 |
| Diagnosis of platelet function disorders: A standardized, rational, and modular flow cytometric approach |
5 |
| 96-well plate-based aggregometry |
5 |
| Evaluation of platelet function in thrombocytopenia |
5 |
| White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds |
5 |
| Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping |
5 |
| Production of platelet-rich plasma gel from elderly patients under antithrombotic drugs: Perspectives in chronic wounds care |
5 |
